Company
Orbus Therapeutics
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies.
Also known as Orbus Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Legal name
- Orbus Therapeutics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
We at Orbus are committed to bringing innovative products to the extremely under served patients affected by rare diseases. We are focused and passionate about bringing a more positive outcome to patients facing life threatening or significantly life altering diseases.
Funding snapshot
- Total raised
- $46.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $10M2020-07-27
Funding rounds
- Round, 2020
- $10M2020-07-27, SEC form D sold, 1 investor
- Round, 2017
- $18.5M2017-08-08, SEC form D sold, 16 investors
- Round, 2015
- $18M2015-08-07, SEC form D sold, 15 investors
Products
- Other
- eflornithine
Loading relationship preview